Cargando…
Food effect on the bioavailability of two distinct formulations of megestrol acetate oral suspension
OBJECTIVE: Megestrol acetate oral suspension (MAOS) is an appetite stimulant indicated for cachexia in patients with AIDS. It is available in its original formulation, Megace(®) (MAOS), and as a nanocrystal dispersion, Megace(®) ES (MA-ES). Three studies were conducted to evaluate the pharmacokineti...
Autores principales: | Deschamps, Benoit, Musaji, Naomi, Gillespie, John A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2747353/ https://www.ncbi.nlm.nih.gov/pubmed/19774117 |
Ejemplares similares
-
Novel nanocrystal formulation of megestrol acetate has improved bioavailability compared with the conventional micronized formulation in the fasting state
por: Jang, Kyungho, et al.
Publicado: (2014) -
Megestrol acetate in cachexia and anorexia
por: Yeh, Shing-shing, et al.
Publicado: (2006) -
Precipitation Reaction of SDS and Potassium Salts in Flocculation of a Micronized Megestrol Acetate Suspension
por: Hejazi, Seyed Mahdi, et al.
Publicado: (2013) -
Megestrol Acetate-Induced Symptomatic Hypogonadism in a Male Patient
por: Munshi, Lubna Bashir, et al.
Publicado: (2018) -
Megestrol acetate for cachexia–anorexia syndrome. A systematic review
por: Ruiz‐García, Vicente, et al.
Publicado: (2018)